The Association for the Accreditation of Human Research Protection Programs, Inc. announced that it has accredited another seven organizations—including its first organizations in India.
Four of the seven newly accredited organizations are outside the United States, underscoring AAHRPP's progress in moving toward one standard worldwide for protecting research participants. All told, 241 organizations have now earned accreditation, including institutions in 45 states, the District of Columbia, Puerto Rico, Canada, China, India, Korea, and Singapore.
The latest accreditations come as AAHRPP celebrates the 10th anniversary of its founding in 2001 and prepares to mark 10 years since the issuance of the first accreditation standards in 2002.
"The goal, a decade ago, was to establish an accrediting organization to strengthen research protections and improve the quality of research," said Marjorie A. Speers, PhD, AAHRPP President and CEO. "Since then, hundreds of organizations have earned the AAHRPP gold seal, demonstrating their commitment to rigorous standards that help protect research participants while ensuring that society continues to reap the benefits of research."
The newly accredited organizations are:
Creighton University, Omaha, Nebraska, USA
Diex Research Sherbrooke, Inc. & Diex Research Montreal, Inc., Sherbrooke, Quebec, Canada
IRB Services, Aurora, Ontario, Canada
Kasturba Hospital, Manipal, Manipal, India
Manipal Hospital Bangalore, Bangalore, India
Texas Health Resources, Arlington, Texas, USA
The University of Alabama, Tuscaloosa, Alabama, USA
For these and all accredited organizations, AAHRPP accreditation translates into significant benefits for research participants and society as a whole.
Accreditation is available to United States and international organizations that conduct biomedical, behavioral or social sciences research involving human participants. The list of accredited organizations includes community and teaching hospitals; VA facilities, universities; institutional review boards; research institutes; and contract research organizations.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.